HIV–infected adults, according to a new study.A vaccine for pneumonia and meningitis has been found to be effective in offering protection against re–infection in
Researchers at a Malawi–Liverpool–Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine in Blantyre, Malawi, studied the efficacy of a vaccine against infection with the Streptococcus pneumoniae bacteria, which causes invasive pneumococcal disease (IPD).
HIV–infected adults, particularly in sub–Saharan Africa, live in an increased risk of developing IPD. Experts tested the efficacy of Prevnar, a pneumococcal conjugate vaccine (PCV) developed by pharmaceutical company Wyeth, on almost five hundred predominantly HIV–infected adults who recovered from IPD after being admitted to the Queen Elizabeth Central Hospital in Blantyre.
Source :Times of India
Sunday, Feb 26th
Last update:05:44:44 AM IST